Culturally Tailored Nutrition Therapy to Improve Dietary Adherence of Type 2 Diabetes Patients in Benin, Africa
Launched by UNIVERSITY OF ARIZONA ·
Trial Information
Current as of September 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special nutrition program called Objectif Santé Diabète Benin (OSanDiaBé), designed specifically for people with type 2 diabetes in Benin, Africa. The goal is to see if this program, which considers local food habits and culture, can help people better manage their diabetes by improving their blood sugar levels (measured by a test called HbA1c) and encouraging healthier eating habits over one year, compared to the usual care they receive.
The study is looking for adults with type 2 diabetes to take part. While the exact age range appears unclear in the information provided, the trial invites all genders to participate. If you join, you can expect to follow a nutrition plan tailored to your culture and lifestyle, with support to help you stick to it. This approach aims to make it easier and more practical for participants to make healthy food choices that fit their daily lives. The trial is not yet recruiting participants but may be a good option for those interested in a personalized way to improve diabetes care through diet.
Gender
ALL
Eligibility criteria
About University Of Arizona
The University of Arizona is a leading research institution dedicated to advancing healthcare through innovative clinical trials and studies. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources and expertise to explore new therapeutic approaches and enhance patient outcomes. Committed to ethical research practices and community engagement, the University of Arizona fosters an environment that promotes scientific discovery and the translation of research findings into clinical applications. Its clinical trial initiatives encompass a wide range of medical disciplines, reflecting the institution's mission to improve health and well-being locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Waliou Amoussa-Hounkpatin, PhD
Principal Investigator
Université d'Abomey-Calavi
Edward Bedric, PhD
Principal Investigator
University of Arizona
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported